Testing for homologous recombination deficiency - does it provide new insights for the use of veliparib?

Gynecol Oncol. 2022 Feb;164(2):243-244. doi: 10.1016/j.ygyno.2022.01.018.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzimidazoles*
  • Homologous Recombination
  • Humans
  • Poly(ADP-ribose) Polymerase Inhibitors*

Substances

  • Benzimidazoles
  • Poly(ADP-ribose) Polymerase Inhibitors
  • veliparib